Scheme 1. Synthesis of the AB Ring System
1
1
as of nagilactone F. Imamura and co-workers utilized
abietic acid as a starting point for the synthesis of an
oidiolactone analogue. Abietic acid was also used by Hayashi
Figure 1
. Structures of naturally occurring norditerpene dilac-
tones and strategic transformations toward a common precursor
1
2
8
.
and co-workers for the semisynthesis of nagilactone F. In
spite of the importance of podolactones as biologically active
natural products, very few reports of their total synthesis
have been disclosed. An enantioselective synthesis of nagi-
lactone F and a synthesis of racemic (()-3ꢀ-hydroxy
6
interrelationships. A collection of natural and synthetic
podolactones have also been tested as allelochemicals for
their potential herbicidal activities. Recently, oidiolactone
7
13
14
nagilactone F were reported by Burke and de Groot,
respectively. Finally, a total synthesis of racemic oidiolactone
B was reported to inhibit production of human interleukin-
1
5
1
ꢀ at a concentration equal to IC50 49 nM. Antagonism of
B was reported by Welch in 1977.
such cytokines can have important effects in the treatment
of inflammatory diseases. Oidiolactone B also displays
We wish to disclose the first enantioselective total
syntheses of oidiolactones A-D and nagilactone F in an
expedient, convergent, and highly stereocontrolled manner.
A disconnective analysis illustrates key steps and the
versatility of our approach that leads to a common intermedi-
ate 8, from which the intended podolactones, as well as other
natural and synthetic analogues, can be easily accessed
8
considerable antifungal activity against opportunistic patho-
2
d
gens such as Candida albicans.
The first semisynthesis of oidiolactone B by Adinolfi and
9
co-workers was reported in 1972, soon after the elucidation
2
c
of its structure by Ellestad and co-workers. The starting
material was marrubiin, a diterpene lactone isolated from
Marrubium Vulgare, that already harbors the C-9 branched
decalin ring and the C-4-C-6 bridged γ-lactone. Barrero and
(Figure 1).
The construction of the AB ring system as a single
enantiomer was initiated from the readily available Wieland-
1
6
1
0
Miescher ketone 9 following literature reports by the
co-workers used trans-communic acid, obtained from the
cones of Juniperus communis, as a naturally occurring chiron
toward the semisynthesis of oidiolactone B and C, as well
1
7
18
Theodorakis and Danishefsky groups, which led to 10
and 11 in good overall yield (Scheme 1). Highly stereose-
lective conjugate reduction of 11 was mediated by Mg in
1
9
1
MeOH to give 12 (95:5 dr by H NMR) in an excellent
yield. Stereoselective methylation of the Li enolate at -78
(
5) Zhang, M.; Ying, B. P.; Kubo, I. J. Nat. Prod. 1992, 55, 1057–
1
062.
°
C afforded the R-methyl branched ester 13 as a single
(
6) (a) Hayashi, Y.; Takahashi, S.; Ona, H.; Sakan, T. Tetrahedron Lett.
1
968, 17, 2071–2076. (b) Kakisawa, H.; Sato, M.; Ruo, T.-i.; Hayashi, T.
J. Chem. Soc., Chem. Commun. 1973, 802–803. (c) Sato, M.; Kakisawa,
H. J. Chem. Soc., Perkin Trans. 1 1976, 2407–2413.
(11) Imamura, P. M.; dos Santos, C. Synth. Commun. 2005, 35, 2057–
2065.
(
7) Mac ´ı as, F. A.; Simonet, A. M.; Pacheco, P. C.; Barrero, A. F.;
(12) Hayashi, Y.; Matsumoto, T.; Nishizawa, M.; Togami, M.; Hyono,
Cabrera, E.; Jim e´ nez-Gonz a´ lez, D. J. Agric. Food Chem. 2000, 48, 3003–
007.
8) (a) Ichikawa, K.; Hirai, H.; Ishiguro, M.; Kambara, T.; Kato, Y.;
Kim, Y. J.; Kojima, Y.; Matsunaga, Y.; Nishida, H.; Shiomi, Y.; Yoshikawa,
N.; Huang, L. H.; Kojima, N. J. Antibiot. 2001, 54, 697–702. (b) Ichikawa,
K.; Ikunaka, M.; Kojima, N.; Nishida, H.; Yoshikawa, N. European Patent
T.; Nishikawa, N.; Uemura, M.; Sakan, T. J. Org. Chem. 1982, 47, 3428–
3433.
3
(
(13) Burke, S. D.; Kort, M. E.; Strickland, S. M. S.; Organ, H. M.; Silks,
L. A., III Tetrahedron Lett. 1994, 35, 1503–1506.
(14) Reuvers, J. T. A.; de Groot, A. J. Org. Chem. 1986, 51, 4594–
4599.
0
933 273 A1, 1999. (c) Ichikawa, K.; Inagaki, T.; Kojima, Y.; Nakamura,
T.; Nishida, H.; Ueno, Y.; Kojima, N. J. Antibiot. 2001, 54, 977–979.
9) Adinolfi, M.; Mangoni, L.; Barone, G.; Laonigro, G. Gazz. Chim.
Ital. 1973, 103, 1271–1279.
10) (a) For the synthesis of oidiolactone C, see: Barrero, A. F.;
(15) Welch, S. C.; Hagan, C. P.; White, D. H.; Fleming, W. P.; Trotter,
J. W. J. Am. Chem. Soc. 1977, 99, 549–556.
(16) Buchschacher, P.; F u¨ rst, A.; Gutzwiller, J. Org. Synth. 1990, 7,
368–372.
(
(
(17) Ling, T.; Chowdhury, C.; Kramer, B. A.; Vong, B. G.; Palladino,
M. A.; Theodorakis, E. A. J. Org. Chem. 2001, 66, 8843–8853.
(18) Waters, S. P.; Tian, Y.; Li, Y.-M.; Danishefsky, S. J. J. Am. Chem.
Soc. 2005, 127, 13514–13515.
Arseniyadis, S.; Qu ´ı lez del Moral, J. F.; Herrador, M. M.; Valdivia, M.;
Jim e´ nez, D. J. Org. Chem. 2002, 67, 2501–2508. (b) For the syntheses of
oidiolactone B and nagilactone F, see: Barrero, A. F.; S a´ nchez, J. F.;
Elmarabet, J.; Jim e´ nez-Gonz a´ lez, D.; Mac ´ı as, F.; Simonet, A. M. Tetra-
hedron 1999, 55, 7289–7304.
(19) Youn, I. K.; Yon, G. H.; Pak, C. S. Tetrahedron Lett. 1986, 27,
2409–2410.
Org. Lett., Vol. 11, No. 20, 2009
4641